I focus on providing patent protection strategies, procurement, and management to emerging and established life science companies.
Dr. Taylor Canady partners with emerging and established life science companies in protecting their valuable IP through all stages of the business life cycle – from initial filing to exit. His practice includes patent prosecution, freedom-to-operate analysis, patentability analysis, IP license due diligence, and competitive intelligence collection.
Taylor has extensive experience in gene editing therapies, siRNA therapies, peptide therapies, antibody and cellular immunotherapies, single cell sequencing, and stem cell technology.
Taylor earned his Ph.D. from Carnegie Mellon University as a McWilliams Fellow where he studied peptide nucleic acid gene regulation and nucleic acid nanotechnology applications. After his Ph.D., he was an Institute for Genomic Biology Fellow at University of Illinois where he developed several innovations which spanned ultra specific nucleic acid detection, single molecule imaging diagnostics, and a new label free imaging modality. This work has been published in well regarded journals such as JACS, PNAS, Nature Comm., Lab on a Chip, ACS Photonics, and ACS Nano.
We use cookies to enhance user experience, improve functionality and performance, and for analysis of website traffic. By clicking “accept”, you agree to the use of cookies. For more information about our cookie policy and the information we collect, please review our Privacy Statement.
Foley Hoag
Email Disclaimer
Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK," you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you.
If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Foley Hoag.
